BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X902. A total of 4 filers reported holding BRIDGEBIO PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,271,115 | +56.4% | 389,500 | +2.0% | 0.04% | +66.7% |
| Q2 2023 | $6,568,680 | +84.1% | 381,900 | +77.5% | 0.02% | +61.5% |
| Q1 2023 | $3,568,016 | +1207.9% | 215,200 | +501.1% | 0.01% | +1200.0% |
| Q4 2022 | $272,796 | -79.3% | 35,800 | -73.1% | 0.00% | -66.7% |
| Q3 2022 | $1,321,000 | +45.8% | 132,900 | +33.2% | 0.00% | +200.0% |
| Q2 2022 | $906,000 | -44.3% | 99,800 | -37.7% | 0.00% | -50.0% |
| Q1 2022 | $1,626,000 | -71.1% | 160,200 | -52.6% | 0.00% | -60.0% |
| Q4 2021 | $5,633,000 | +603.2% | 337,700 | +1874.9% | 0.01% | +400.0% |
| Q3 2021 | $801,000 | -0.5% | 17,100 | +29.5% | 0.00% | 0.0% |
| Q2 2021 | $805,000 | -65.7% | 13,200 | -65.4% | 0.00% | -66.7% |
| Q1 2021 | $2,347,000 | -31.4% | 38,100 | -20.8% | 0.00% | -50.0% |
| Q4 2020 | $3,420,000 | +195.1% | 48,100 | +55.7% | 0.01% | +50.0% |
| Q3 2020 | $1,159,000 | -66.4% | 30,900 | -70.8% | 0.00% | -75.0% |
| Q2 2020 | $3,453,000 | +294.2% | 105,900 | +250.7% | 0.02% | +128.6% |
| Q1 2020 | $876,000 | – | 30,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 35,800 | $272,796 | 0.00% |
| SIMPLEX TRADING, LLC | 79,200 | $603 | 0.00% |
| JANE STREET GROUP, LLC | 17,500 | $133,350 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |